A
AXSM
Axsome Therapeut
207.77
-0.26-0.13%After Hours: 207.77 0.00 0.00%19:30 08/21 EDT
OPEN/PREV CLOSE207.22/208.03
TODAY RANGE206.50-210.87
VOL734.95K
MARKET CAP10.88B
52 WEEK RANGE109.40-260.19
AVG VOL (3M)874.16K
% TURNOVER1.40%
TURNOVER--
P/E (TTM)-55.2668
% RANGE2.10%
EPS(TTM)-3.7594
P/E(FORWARD)-77.9715
P/B130.44
BVPS1.593
DIVIDEND--
P/S16.56
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.19B
SHARES OUTSTANDING52.38M
NEXT EARNINGS11/02-11/06
FREE FLOAT44.24M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·6d ago
Here’s How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years
Seeking Alpha·08/15 10:37
What Moved Markets This Week
TipRanks·08/14 16:30
Axsome Targets Smoking Cessation With New Phase 3 AXS-05 Trial
Benzinga·08/13 23:00
If You Invested $100 In Axsome Therapeutics Stock 10 Years Ago, You Would Have This Much Today
Dow Jones·08/12 12:59
Axsome Therapeutics Is Maintained at Outperform by Mizuho
Dow Jones·08/12 12:59
Axsome Therapeutics Price Target Raised to $316.00/Share From $306.00 by Mizuho
Benzinga·08/12 12:49
Mizuho Maintains Outperform on Axsome Therapeutics, Raises Price Target to $316
TipRanks·08/12 10:36
Axsome Therapeutics (AXSM) Receives a Buy from Mizuho Securities
Seeking Alpha·08/11 16:25
Axsome Therapeutics Q2 Earnings Review: I Just Can't See The Value Proposition
Dow Jones·08/11 16:00
Axsome Therapeutics Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones·08/11 15:22
Axsome Therapeutics Price Target Cut to $297.00/Share From $304.00 by RBC Capital
Dow Jones·08/11 15:22
Axsome Therapeutics Is Maintained at Outperform by RBC Capital
Same Industry
Name/Symbol
Change%
Price